-
Notifications
You must be signed in to change notification settings - Fork 417
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Can be tumor-only somatic variant calling performed using Strelka? #803
Comments
Hi @ariadnaaterrades ! Can you please post some more details: command run, samplesheet, any other configs/param files you are using, and the nextflow log? |
Hi @FriederikeHanssen , thanks for your quick reply. I've been using mainly the default parameters with GRCh38 genome version , here is the command run:
The sample sheet looks like this:
And the thing is that there is no error in the execution_report_2022-10-11_13-00-30.html file...all the processes seem to be complete correctly. I did end up having output files, but not the somatic ones. For that reason I decided to look at the strelka tool information and I realized that it might not be possible to run tumor-only somatic variant calling. |
Hey! Apologies for the late reply, I was OOO, but back now. So strelka is run with the following command for tumor-only samples: https://github.com/nf-core/sarek/blob/master/modules/nf-core/modules/strelka/germline/main.nf So with the "germline" module which is the only one we have available now as you correctly noted. However, there should still be the respective output present for you sample names. If that is the case, then the output is as expected and we can close the issue. The somatic ones can only be called with paired samples to my knowledge. |
Hi! As you mention, I ended up having germline results instead of somatic ones. However, I decided to run strelka among other methods to perform tumor-only somatic variant calling because in your website indicates that it would be possible to do so. https://nf-co.re/sarek/3.0.2/parameters As you said, according to strelka's paper: https://academic.oup.com/bioinformatics/article/28/14/1811/218573 it is not possible to run it but when I saw your website information I thought that you may have implemented some changes in order to be capable of running it. I think that changing the website information could prevent other people from misunderstanding. Thank you so much! |
<!-- # nf-core/sarek pull request Many thanks for contributing to nf-core/sarek! Please fill in the appropriate checklist below (delete whatever is not relevant). These are the most common things requested on pull requests (PRs). Remember that PRs should be made against the dev branch, unless you're preparing a pipeline release. Learn more about contributing: [CONTRIBUTING.md](https://github.com/nf-core/sarek/tree/master/.github/CONTRIBUTING.md) --> Closes #803. I have removed `strelka` **tumor-only somatic variant calling** from the `bam_variant_calling_tumor_only_all` subworkflow. Also i have updated the subway image, docs and tests. Maybe we should leave the PR open for a few days to see if anyone complains about removing it: https://nfcore.slack.com/archives/CGFUX04HZ/p1730110553053079 ## PR checklist - [x] This comment contains a description of changes (with reason). - [ ] If you've fixed a bug or added code that should be tested, add tests! - [ ] If you've added a new tool - have you followed the pipeline conventions in the [contribution docs](https://github.com/nf-core/sarek/tree/master/.github/CONTRIBUTING.md) - [ ] If necessary, also make a PR on the nf-core/sarek _branch_ on the [nf-core/test-datasets](https://github.com/nf-core/test-datasets) repository. - [ ] Make sure your code lints (`nf-core lint`). - [ ] Ensure the test suite passes (`nextflow run . -profile test,docker --outdir <OUTDIR>`). - [ ] Check for unexpected warnings in debug mode (`nextflow run . -profile debug,test,docker --outdir <OUTDIR>`). - [ ] Usage Documentation in `docs/usage.md` is updated. - [ ] Output Documentation in `docs/output.md` is updated. - [ ] `CHANGELOG.md` is updated. - [ ] `README.md` is updated (including new tool citations and authors/contributors). --------- Co-authored-by: fmartinez <fmartinez@incliva.es>
Description of the bug
As you mention in your Nextflow pipeline: @https://nf-co.re/sarek/3.0.2/parameters it would be possible to obtain the results of tumor-only somatic variant calling using strelka tool (among other methods).
I've run the pipeline using strelka with tumor-only samples and I've ended up having results for germline variants (variants.vcf.gz, genome.S${N}.vcf.gz) instead of somatic ones (somatic.snvs.vcf.gz, somatic.indels.vcf.gz) (@https://github.com/Illumina/strelka/blob/v2.9.x/docs/userGuide/README.md ).
I read that strelka can perform somatic variant calling when you have tumor-normal samples pairs, however it is not possible to do so when you have tumor-only samples. @https://academic.oup.com/bioinformatics/article/28/14/1811/218573. Did I miss any extra parameter?
Sorry in advance if i misunderstood something.
Command used and terminal output
No response
Relevant files
No response
System information
No response
The text was updated successfully, but these errors were encountered: